Clinical trial
A Prospective, Multicenter Study of O-RADS MRI System on Early Detection of Ovarian Cancer
NCT07009743 is registered in ClinicalTrials.gov with Shanghai Gynecologic Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Study of O-RADS MRI System on Early Detection of Ovarian Cancer
- Lead sponsor
- Shanghai Gynecologic Oncology Group
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 1, 2025
- Completion date
- December 31, 2028
- Enrollment
- 2,549 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer (ovca), ovarian cancer metastatic